Amicus Therapeutics, Inc. (FOLD)

14.30 +0.02 (+0.11%) USD  |  NASDAQ  |  Jan 07, 16:00
14.29 0.00 (0.00%) After-Hours: 18:01
More

Amicus Therapeutics Research and Development Expense (Annual): 109.36M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for FOLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 747.18M
CorMedix, Inc. 3.942M
ANI Pharmaceuticals, Inc. 44.58M
Gilead Sciences, Inc. 5.816B
ACADIA Pharmaceuticals, Inc. 303.25M